ArticleScientific reports2025
Phytosphingosine, a sphingolipid isolated from fungal endophyte Penicillium oxalicum, exerts cytotoxic effects against breast cancer cells and shows blood compatibility.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Plant-associated fungal endophytes hold great potential to synthesize metabolites similar to their host, with potential anticancer effects. The present study aims to identify lead compound in the ethyl acetate (EA) extract of fungal endophyte, Penicillium oxalicum, associated with a medicinal plant Amoora rohituka, responsible for the anti-breast cancer activity. The crude extract of P. oxalicum was subjected to High-performance liquid chromatography (HPLC) analysis and further, bioactivity-guided fractionation was performed for HPLC fractions based on cell viability assay. The potential fraction further showed dose-dependent generation of nitric oxide in breast cancer cells that indicates their activity in the induction of oxidative stress. The characterization of potential fraction was done using different analytical techniques, such as liquid chromatography coupled with quadrupole time of flight mass spectrometry (LC-Q-TOF-MS), high-resolution mass spectrometry (HRMS), Fourier transform-infrared (FTIR) spectroscopy, and both
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.